Zubair Anwar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zubair Anwar has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Ali Sheraz
Department of Pharmaceutics, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
21 shared publications - Sofia Ahmed
Department of Pharmaceutics, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
19 shared publications Iqbal Ahmad
Department of Pharmaceutical Chemistry, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Super Highway, Gadap Road, Karachi, Pakistan
16 shared publicationsSofia Ahmed
Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
14 shared publications- Iqbal Ahmad
Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
12 shared publications Muhammad Ali Sheraz
Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
11 shared publications
Latest Publications
- Open Access
- 7 May 2026
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 21 (3) , 468-475
Evaluation of antibacterial efficiency of Trapa natans modified glass ionomer cement: An in vitro study
- 7 May 2026
- Published by Elsevier in Journal of Taibah University Medical Sciences
- Vol. 21 (3) , 468-475
Open AccessEvaluation of antibacterial efficiency of Trapa natans modified glass ionomer cement: An in vitro study
- 29 April 2026
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 23 (5) , 120
Thermal degradation kinetics of tolfenamic acid in liquid media: a combined experimental and QSPR–machine learning study
- 29 April 2026
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 23 (5) , 120
Thermal degradation kinetics of tolfenamic acid in liquid media: a combined experimental and QSPR–machine learning study
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Anti-Infective Agents
- Vol. 24 (1)
Spectrofluorimetric and Spectrophotometric Methods for the Determination of Ciprofloxacin HCl and Their Comparison with the Compendial High-Performance Liquid Chromatography (HPLC) Method
Introduction: Ciprofloxacin hydrochloride (CH) is a widely used fluoroquinolone antibiotic. Accurate, cost-effective methods are essential for its routine quality control. This study aimed to develop and validate simple UV spectrophotometric and spectrofluorimetric methods for quantifying CH in bulk and pharmaceutical formulations. Methods: UV analysis was performed at 271 nm, while fluorescence measurements were taken at 335 nm (excitation) and 416 nm (emission) in phosphate buffer (pH 7). Validation was conducted in accordance with the International Council for Harmonisation (ICH) guidelines for linearity, accuracy, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), robustness, and solution stability. Results were compared with an official HPLC method. Results: Both methods demonstrated excellent linearity in the range of 0.4-2.0 × 10⁻⁵ M (r² = 0.9999). The limits of detection (LOD) and quantification (LOQ) were 0.64/1.95 × 10⁻⁶ M for the UV method and 0.66/1.99 × 10⁻⁶ M for the fluorescence method. Recovery values ranged from 99.27% to 99.92% (UV) and 98.60% to 100.32% (fluorescence), with %RSD values below 2%, indicating good precision. Robustness testing revealed minimal effects from deliberate variations in experimental conditions, and the results showed strong agreement with the compendial HPLC method Discussion: UV spectrophotometric and spectrofluorimetric methods proved to be accurate, sensitive, and reproducible. The UV method is ideal for basic lab setups, while fluorescence offers greater sensitivity for lower concentrations. Comparable results with HPLC confirm their suitability. Conclusion: Validated UV and fluorescence methods provide efficient, accurate, and lowcost alternatives to HPLC for quality control of CH in pharmaceutical analysis.
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Anti-Infective Agents
- Vol. 24 (1)
Spectrofluorimetric and Spectrophotometric Methods for the Determination of Ciprofloxacin HCl and Their Comparison with the Compendial High-Performance Liquid Chromatography (HPLC) Method
Introduction: Ciprofloxacin hydrochloride (CH) is a widely used fluoroquinolone antibiotic. Accurate, cost-effective methods are essential for its routine quality control. This study aimed to develop and validate simple UV spectrophotometric and spectrofluorimetric methods for quantifying CH in bulk and pharmaceutical formulations. Methods: UV analysis was performed at 271 nm, while fluorescence measurements were taken at 335 nm (excitation) and 416 nm (emission) in phosphate buffer (pH 7). Validation was conducted in accordance with the International Council for Harmonisation (ICH) guidelines for linearity, accuracy, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), robustness, and solution stability. Results were compared with an official HPLC method. Results: Both methods demonstrated excellent linearity in the range of 0.4-2.0 × 10⁻⁵ M (r² = 0.9999). The limits of detection (LOD) and quantification (LOQ) were 0.64/1.95 × 10⁻⁶ M for the UV method and 0.66/1.99 × 10⁻⁶ M for the fluorescence method. Recovery values ranged from 99.27% to 99.92% (UV) and 98.60% to 100.32% (fluorescence), with %RSD values below 2%, indicating good precision. Robustness testing revealed minimal effects from deliberate variations in experimental conditions, and the results showed strong agreement with the compendial HPLC method Discussion: UV spectrophotometric and spectrofluorimetric methods proved to be accurate, sensitive, and reproducible. The UV method is ideal for basic lab setups, while fluorescence offers greater sensitivity for lower concentrations. Comparable results with HPLC confirm their suitability. Conclusion: Validated UV and fluorescence methods provide efficient, accurate, and lowcost alternatives to HPLC for quality control of CH in pharmaceutical analysis.
- 26 December 2025
- Published by Elsevier
- Vol. 51, 1-76
Vortioxetine: A comprehensive profile
- Open Access
- 18 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (53) , 45799-45821
Riboflavin-sensitized photoinduced degradation of donepezil hydrochloride: kinetic and computational insights for pharmaceutical formulation
Donepezil (DPZ) photosensitized degradation by riboflavin (RF) at pH 2.0–12.0 has been carried out in aerobic and anaerobic conditions under UV and visible irradiation to give an idea to pharmaceutical formulators to develop a stable co-formulation to administer to elderly patients with neurodegenerative diseases (Alzheimer's disease, Parkinson's disease). The photolysis rate constants (kobs) in aerobic and anaerobic conditions in the presence of RF (0.1–0.5 × 10−4 M) range from 0.25–11.5 and 0.025–1.120 × 10−2 min−1, respectively. RF catalyzes the photodegradation of DPZ, and the second-order (k2) constants in aerobic and anaerobic conditions range from 0.32 to 8.22 and 0.032 to 0.805 × 10−2 M−1 min−1, respectively, indicating that with an increase in the concentrations of RF, the rate of photolysis of DPZ also increases. The k-pH profile shows a bell-shaped curve from pH 2.0 to 4.0 and from pH 5.0 to 12.0, forming a sigmoid curve. The two-component spectrometric and HPLC green methods have been developed and validated for estimating DPZ and RF in pure and degraded solutions. Additionally, computational studies have been conducted to assess the formation of the ground-state complex, binding affinity, and molecular interactions between DPZ and RF.
- 18 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (53) , 45799-45821
Open AccessRiboflavin-sensitized photoinduced degradation of donepezil hydrochloride: kinetic and computational insights for pharmaceutical formulation
Donepezil (DPZ) photosensitized degradation by riboflavin (RF) at pH 2.0–12.0 has been carried out in aerobic and anaerobic conditions under UV and visible irradiation to give an idea to pharmaceutical formulators to develop a stable co-formulation to administer to elderly patients with neurodegenerative diseases (Alzheimer's disease, Parkinson's disease). The photolysis rate constants (kobs) in aerobic and anaerobic conditions in the presence of RF (0.1–0.5 × 10−4 M) range from 0.25–11.5 and 0.025–1.120 × 10−2 min−1, respectively. RF catalyzes the photodegradation of DPZ, and the second-order (k2) constants in aerobic and anaerobic conditions range from 0.32 to 8.22 and 0.032 to 0.805 × 10−2 M−1 min−1, respectively, indicating that with an increase in the concentrations of RF, the rate of photolysis of DPZ also increases. The k-pH profile shows a bell-shaped curve from pH 2.0 to 4.0 and from pH 5.0 to 12.0, forming a sigmoid curve. The two-component spectrometric and HPLC green methods have been developed and validated for estimating DPZ and RF in pure and degraded solutions. Additionally, computational studies have been conducted to assess the formation of the ground-state complex, binding affinity, and molecular interactions between DPZ and RF.
- Open Access
- 26 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Pharmaceutics
- Vol. 2 (6) , 1580-1592
Chitosan-based biodegradable dental chips impregnated with chlorhexidine gluconate for the treatment of periodontitis
The steps for the preparation of chitosan chips containing chlorhexidine for the treatment of periodontitis.
- 26 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Pharmaceutics
- Vol. 2 (6) , 1580-1592
Open AccessChitosan-based biodegradable dental chips impregnated with chlorhexidine gluconate for the treatment of periodontitis
The steps for the preparation of chitosan chips containing chlorhexidine for the treatment of periodontitis.
- Open Access
- 29 August 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (38) , 31194-31209
Cyclodextrin-assisted photostabilization of 5-fluorouracil: a combined kinetic and computational investigation
The photostabilization of 5-fluorouracil (5-FU) has been carried out in the pH range of 2.0–12.0 using cyclodextrins (α-, β-, γ-) as a complexing agent. The inclusion complex formation between 5-FU and CDs has been evaluated using conductometry, FTIR spectroscopy, NMR spectroscopy, differential scanning calorimetry (DSC), and molecular docking simulations. The loss of absorbance at 266 nm for 5-FU in the presence of CDs indicates its photodegradation. The entrapment of 5-FU in α-, β-, and γ-CDs ranges from 22.0–58.0, 30.0–64.0, and 42.0–77.0%, respectively, indicating the formation of inclusion complexes of CDs with 5-FU. The values of Stern–Volmer fluorescence quenching constants and binding constants for α-, β- and γ-CDs are 1.10, 1.69, 3.06 × 103 L mol−1 and 2.89, 3.11, 3.62 103 L mol−1, respectively. The apparent first-order rate constants (kobs) for the photodegradation of 5-FU in the presence of α-, β-, and γ-CDs are 1.75–5.12, 1.21–4.89, and 0.85–4.69 × 103, min−1, respectively. The photochemical interaction (k2) of 5-FU with α-, β-, and γ-CDs ranges from 0.25–0.49, 0.63–1.47, and 0.79–2.14 M−1 min−1 in the pH range 2.0–12.0. The mode of photochemical interaction of 5-FU and CDs and the photostabilization of 5-FU is described based on H–atom abstraction by 5-FU from CD and radical–radical recombination. The computational analysis complemented the experimental findings, showing a significant second-order donor–acceptor interaction, particularly LP → π*, between the hydroxyl groups of γ-CD and the carbonyl groups of 5-FU. The natural population analysis further revealed a shift in electron density from γ-CD to 5-FU, indicating a protective charge-transfer mechanism that contributes to the photostabilization of 5-FU.
- 29 August 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (38) , 31194-31209
Open AccessCyclodextrin-assisted photostabilization of 5-fluorouracil: a combined kinetic and computational investigation
The photostabilization of 5-fluorouracil (5-FU) has been carried out in the pH range of 2.0–12.0 using cyclodextrins (α-, β-, γ-) as a complexing agent. The inclusion complex formation between 5-FU and CDs has been evaluated using conductometry, FTIR spectroscopy, NMR spectroscopy, differential scanning calorimetry (DSC), and molecular docking simulations. The loss of absorbance at 266 nm for 5-FU in the presence of CDs indicates its photodegradation. The entrapment of 5-FU in α-, β-, and γ-CDs ranges from 22.0–58.0, 30.0–64.0, and 42.0–77.0%, respectively, indicating the formation of inclusion complexes of CDs with 5-FU. The values of Stern–Volmer fluorescence quenching constants and binding constants for α-, β- and γ-CDs are 1.10, 1.69, 3.06 × 103 L mol−1 and 2.89, 3.11, 3.62 103 L mol−1, respectively. The apparent first-order rate constants (kobs) for the photodegradation of 5-FU in the presence of α-, β-, and γ-CDs are 1.75–5.12, 1.21–4.89, and 0.85–4.69 × 103, min−1, respectively. The photochemical interaction (k2) of 5-FU with α-, β-, and γ-CDs ranges from 0.25–0.49, 0.63–1.47, and 0.79–2.14 M−1 min−1 in the pH range 2.0–12.0. The mode of photochemical interaction of 5-FU and CDs and the photostabilization of 5-FU is described based on H–atom abstraction by 5-FU from CD and radical–radical recombination. The computational analysis complemented the experimental findings, showing a significant second-order donor–acceptor interaction, particularly LP → π*, between the hydroxyl groups of γ-CD and the carbonyl groups of 5-FU. The natural population analysis further revealed a shift in electron density from γ-CD to 5-FU, indicating a protective charge-transfer mechanism that contributes to the photostabilization of 5-FU.
- Open Access
- 19 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0330554
Correction: High-performance liquid chromatographic method for determination of voriconazole in pure and gel formulation
[This corrects the article DOI: 10.1371/journal.pone.0315704.].
- 19 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0330554
Open AccessCorrection: High-performance liquid chromatographic method for determination of voriconazole in pure and gel formulation
[This corrects the article DOI: 10.1371/journal.pone.0315704.].
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
PEGylated chitosan xerogels for localized periodontal therapy: design, characterization, and drug release
It is essential to adopt effective therapy strategies for periodontal diseases to achieve optimal results while avoiding adverse effects on the system. This study has developed various PEGylated chitosan-based biodegradable xerogels for localized release of doxycycline hyclate (DH) to treat periodontal infectious diseases. The xerogels were formulated using the solvent casting method, and the solvent (0.25 M HCl) was slowly evaporated at ambient conditions. Two different molecular weights were employed for chitosan and polyethylene glycol, and twelve combinations, including the placebos and controls, were prepared for the formulation of xerogels. Different physical and chemical characteristics of the prepared DH xerogels were studied, such as drying time and rate, thickness, moisture content, swelling index, organoleptic characteristics, scanning electron microscopy, FTIR spectrometry, differential scanning calorimetry, drug release and kinetics, and antibacterial activity. The results revealed that the drug transforms from a crystalline to an amorphous state, thus rapidly releasing the drug (> 60% in 30 min. in all xerogels), followed by a sustained release up to 10 h. The release kinetics results revealed that the drug followed the Korsmeyer–Peppas model. It is concluded that the formulated DH-loaded xerogels showed promising results for use in the periodontal pockets to treat various infectious diseases.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Open AccessPEGylated chitosan xerogels for localized periodontal therapy: design, characterization, and drug release
It is essential to adopt effective therapy strategies for periodontal diseases to achieve optimal results while avoiding adverse effects on the system. This study has developed various PEGylated chitosan-based biodegradable xerogels for localized release of doxycycline hyclate (DH) to treat periodontal infectious diseases. The xerogels were formulated using the solvent casting method, and the solvent (0.25 M HCl) was slowly evaporated at ambient conditions. Two different molecular weights were employed for chitosan and polyethylene glycol, and twelve combinations, including the placebos and controls, were prepared for the formulation of xerogels. Different physical and chemical characteristics of the prepared DH xerogels were studied, such as drying time and rate, thickness, moisture content, swelling index, organoleptic characteristics, scanning electron microscopy, FTIR spectrometry, differential scanning calorimetry, drug release and kinetics, and antibacterial activity. The results revealed that the drug transforms from a crystalline to an amorphous state, thus rapidly releasing the drug (> 60% in 30 min. in all xerogels), followed by a sustained release up to 10 h. The release kinetics results revealed that the drug followed the Korsmeyer–Peppas model. It is concluded that the formulated DH-loaded xerogels showed promising results for use in the periodontal pockets to treat various infectious diseases.